MAGELLAN HEALTH INC Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020	Q1 FY2020 As of Mar 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q3 FY2019 As of Sep 30, 2019	Q2 FY2019 As of Jun 30, 2019	Q1 FY2019 As of Mar 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q3 FY2018 As of Sep 30, 2018	Q2 FY2018 As of Jun 30, 2018	Q1 FY2018 As of Mar 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q3 FY2017 As of Sep 30, 2017	Q2 FY2017 As of Jun 30, 2017	Q1 FY2017 As of Mar 31, 2017	Q4 FY2016 As of Dec 31, 2016
Assets
Current Assets:
Cash and cash equivalents ($160,967 and $171,047 restricted at December 31, 2018 and September 30, 2019, respectively)
Cash and cash equivalents ($49,227 and $79,746 restricted at December 31, 2020 and September 30, 2021, respectively)
Accounts receivable, net
Short-term investments ($88,867 and $101,884 restricted at December 31, 2020 and September 30, 2021, respectively)
Pharmaceutical inventory
Other current assets ($43,547 and $74,385 restricted at December 31, 2020 and September 30, 2021, respectively)
Current portion of assets held for sale
Total Current Assets
Property and equipment, net
Long-term investments ($1,026 and $0 restricted at December 31, 2020 and September 30, 2021, respectively)
Deferred income taxes
Other long-term assets
Goodwill
Other intangible assets, net
Assets held for sale, less current portion
Total Assets
LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST AND STOCKHOLDERS' EQUITY
Current Liabilities:
Accounts payable
Accrued liabilities
Short-term contingent consideration
Medical claims payable
Other medical liabilities
Current debt, finance lease and deferred financing obligations
Current portion of liabilities held for sale
Total Current Liabilities
Long-term debt, finance lease and deferred financing obligations
Deferred income taxes
Tax contingencies
Long-term contingent consideration
Deferred credits and other long-term liabilities
Liabilities held for sale, less current portion
Total Liabilities
Redeemable non-controlling interest
Stockholder's Equity:
Common stock, par value $.01 per share: Authorized-100,000 shares at December 31, 2020 and September 30, 2021-Issued and outstanding-55,549 and 25,887 shares at December 31, 2020, respectively, and 55,994 and 26,332 shares at September 30, 2021, respectively
Ordinary common stock
Total common stock, par value $.01 per share: Authorized-100,000 shares at December 31, 2020 and September 30, 2021-Issued and outstanding-55,549 and 25,887 shares at December 31, 2020, respectively, and 55,994 and 26,332 shares at September 30, 2021, respectively

Other Stockholders' Equity:
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Treasury stock, at cost, 29,662 and 29,662 shares at December 31, 2020 and September 30, 2021, respectively
Total Stockholders' Equity
Total Liabilities, Redeemable Non-Controlling Interest and Stockholders' Equity

Comments